Opus Genetics

(NASDAQ) OCUP

Current PriceN/A

Market CapN/A

Since IPO (2020)-26%

5 Year-6%

1 Year+321%

1 Month-20%

Opus Genetics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$4.37M

Net Income (TTM)

$106.93M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

OCUP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Opus Genetics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

George Magrath, III, MD

Website

opusgtx.com

Headquarters

Farmington Hills, MI 48335, US

OCUP Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

-4%

Net Income Margin

-9%

Return on Equity

61%

Return on Capital

-75%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$38.60M

EBITDA

$38.60M

Operating Cash Flow

$35.25M

Capital Expenditure

$0.00

Free Cash Flow

$35.25M

Cash & ST Invst.

$45.09M

Total Debt

$0.00

Opus Genetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$65.53M

-699.8%

EBITDA

$14.36M

-44.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$59.96M

+43.5%

Accounts Receivable

$2.71M

-42.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.60%

N/A

Return on Invested Capital

-74.91%

N/A

Free Cash Flow

$12.73M

-41.5%

Operating Cash Flow

$12.73M

-41.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GRCEGrace Therapeutics, Inc.

GRCEGrace Therapeutics, Inc.$2.24+2.75%

MRNSMarinus Pharmaceuticals, Inc.

MRNSMarinus Pharmaceuticals, Inc.$0.55+0.00%

ANGNAngion Biomedica Corp.

ANGNAngion Biomedica Corp.$1.00+0.00%

ALLKAllakos Inc.

ALLKAllakos Inc.$0.33+0.22%

LIANYLianBio

LIANYLianBio$0.11+0.00%

LMNLLiminal BioSciences Inc.

LMNLLiminal BioSciences Inc.$8.50+0.12%

FRLNFreeline Therapeutics Holdings plc

FRLNFreeline Therapeutics Holdings plc$6.49+0.15%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

QBTSD-Wave Quantum

QBTSD-Wave Quantum$25.74+0.33%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.59+0.05%

INTCIntel

INTCIntel$118.50-0.00%

INFQInfleqtion

INFQInfleqtion $14.70+0.31%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.72+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.95+0.01%

FFord Motor Company

FFord Motor Company$13.67+0.03%

Questions About OCUP

What is the current price of Opus Genetics?

Opus Genetics is trading at N/A per share.

What is the 52-week range for Opus Genetics?

Over the past 52 weeks, Opus Genetics has traded between N/A and N/A.

How much debt does Opus Genetics have?

As of the most recent reporting period, Opus Genetics reported total debt of $25.93M.

How much cash does Opus Genetics have on hand?

Opus Genetics reported $59.96M in cash and cash equivalents in its most recent financial results.

What is Opus Genetics’s dividend yield?

Opus Genetics does not currently have a dividend yield.

Opus Genetics

Opus Genetics Financials at a Glance

OCUP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Opus Genetics

OCUP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Opus Genetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OCUP

What is the current price of Opus Genetics?

What is the 52-week range for Opus Genetics?

How much debt does Opus Genetics have?

How much cash does Opus Genetics have on hand?

What is Opus Genetics’s dividend yield?

Premium Investing Services